Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.

MLA

Biegus, Jan, et al. “Impact of Empagliflozin on Decongestion in Acute Heart Failure: The EMPULSE Trial.” European Heart Journal, vol. 44, no. 1, Jan. 2023, pp. 41–50. EBSCOhost, https://doi.org/10.1093/eurheartj/ehac530.

APA

Biegus, J., Voors, A. A., Collins, S. P., Kosiborod, M. N., Teerlink, J. R., Angermann, C. E., Tromp, J., Ferreira, J. P., Nassif, M. E., Psotka, M. A., Brueckmann, M., Salsali, A., Blatchford, J. P., & Ponikowski, P. (2023). Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. European Heart Journal, 44(1), 41–50. https://doi.org/10.1093/eurheartj/ehac530

Chicago

Biegus, Jan, Adriaan A Voors, Sean P Collins, Mikhail N Kosiborod, John R Teerlink, Christiane E Angermann, Jasper Tromp, et al. 2023. “Impact of Empagliflozin on Decongestion in Acute Heart Failure: The EMPULSE Trial.” European Heart Journal 44 (1): 41–50. doi:10.1093/eurheartj/ehac530.